South African Medical News

Back to Home Page

Print using browser
Betacor and Ziabeta - Bisoprolol fumarate and Bisoprolol fumarate + Hydrochlorothiazide (Merck)

merck2019logo




Dear Healthcare Professional


Repatriation of Betacor and Ziabeta back to Merck (Pty) Ltd.

As of 15 December 2018, Betacor and Ziabeta will no longer be marketed by Zentiva, a Sanofi Company.

DSV orders for these brands will need to be placed under the manufacturer, Merck (Pty) Ltd, after this date. There will be different DSV codes but all other details of these brands will remain the same

If you have any further queries, please contact your Merck representative.

For adverse events reporting, please contact: drug.safety.southeastafrica@merckgroup.com or +27 11 372 5304 (Fax line).

  • This is a drug - read the leaflet carefully before use 
  • Ask your doctor or pharmacist for further information.

Merck assure you of their commitment to service excellence at all times.

For full prescribing information refer to the package insert approved by the medicines regulatory authority.

S3 Betacor 5 mg tablets. Each tablet contains bisoprolol fumarate 5 mg. S3 Betacor 10 mg tablets. Each tablet contains bisoprolol fumarate 10 mg.
S3 Ziabeta 2.5/6.25mg. Each tablet contains bisoprolol fumarate 2.5 mg and hydrochlorothiazide 6.258 mg.
S3 Ziabeta 5/6.25mg. Each tablet contains bisoprolol fumarate 5 mg and hydrochlorothiazide 6.258 mg.
S3 Ziabeta 10/6.25mg. Each tablet contains bisoprolol fumarate 10 mg and hydrochlorothiazide 6.258 mg.

Merck (Pty) Ltd ยท South Africa. 1 Friesland Drive, Longmeadow Business, Estate South, Modderfontein, 1609



You need to be logged in to see more details. Register Now!


Click here to visit the Merck website.....
Contact: Dudu Seikaneng, Cardiovascular Brand Manager
Telephone: +27 (0) 11 372-5000
E-mail: dudu.seikaneng@merckgroup.com
Date: Tuesday, January 15, 2019